Evaluation of galectin-8 expression in thyroid tumors

Medical Oncology

Volumn 26, Issue 3, 2009, Pages 314-318

  Savin, S ^a   Cvejic D ^a   Jankovic M ^a   Isic T ^a   Paunovic I ^b   Tatic S ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Galectin 8; Immunohistochemical markers; Thyroid tumors

Indexed keywords

BIOLOGICAL MARKER; GALECTIN 8; PROTEIN;

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL EVALUATION; DIFFERENTIAL DIAGNOSIS; EMBEDDING; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; STAINING; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICULAR ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TUMOR VOLUME;

ADENOMA; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; GALECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; PARAFFIN EMBEDDING; THYROID NEOPLASMS;

EID: 77954083975     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9122-7     Document Type: Article

References (30)

1. AS Fassina MC Montesco V Ninfo P Denti G Masarotto 1993 Histological evaluation of thyroid carcinomas: reproducibility of the "WHO" classification Tumori 79 314 20 8116073 1:STN:280:DyaK2c7mtVektA%3D%3D
2. RV Lloyd, et al. 2004 Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma Am J Surg Pathol 28 1336 40 10.1097/01.pas.0000135519.34847.f6 15371949 10.1097/01.pas.0000135519.34847.f6 (Pubitemid 39336372)
3. S Raphael 2002 The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia Endocr Pathol 13 301 11 10.1385/EP:13:4:301 12665648 10.1385/EP:13:4:301 (Pubitemid 36237984)
4. S Fisher SL Asa 2007 Application of immunohistochemistry to thyroid neoplasms Arch Lab Pathol Med 132 359 72
5. NL Perillo ME Marcus LG Baum 1998 Galectins: versatile modulators of cell adhesion, cell proliferation and cell death J Mol Med 76 402 12 10.1007/s001090050232 9625297 10.1007/s001090050232 1:CAS:528:DyaK1cXjsleku7k%3D (Pubitemid 28218642)
6. H Leffler 2001 Galectins: structure and function-a synopsis Results Probl Cell Differ 33 57 83 11190679 1:STN:280:DC%2BD3M3gtFCqsQ%3D%3D
7. RC Hughes 2001 Galectins as modulators of cell adhesion Biochimie 83 667 76 10.1016/S0300-9084(01)01289-5 11522396 10.1016/S0300-9084(01)01289-5 1:STN:280:DC%2BD3MvnvVyisA%3D%3D (Pubitemid 32821230)
8. RY Yang FT Liu 2003 Galectins in cell growth and apoptosis Cell Mol Life Sci 60 267 76 10.1007/s000180300022 12678492 10.1007/s000180300022 1:CAS:528:DC%2BD3sXns1Wksrs%3D (Pubitemid 36343907)
9. A Danguy I Camby R Kiss 2002 Galectins and cancer Biochem Biophys Acta 1572 285 93 12223276 1:CAS:528:DC%2BD38XmvVagsb8%3D
10. F Van den Brule S Califice V Castronovo 2004 Expressions of galectins in cancer: a critical review Glycoconj J 19 537 42 10.1023/B:GLYC.0000014083.48508. 6a 14758077 10.1023/B:GLYC.0000014083.48508.6a
11. H Lahm, et al. 2004 Tumor galectinology: insights into the complex network of a family of endogenous lectins Glycoconj J 20 227 38 10.1023/B:GLYC.0000025817.24297.17 15115907 10.1023/B:GLYC.0000025817.24297.17 1:CAS:528:DC%2BD2cXjsV2ns7c%3D
12. H Leffler S Carlsson M Hedlund Y Qian F Poirier 2004 Introduction to galectins Glycoconj J 19 433 40 10.1023/B:GLYC.0000014072.34840.04 14758066 10.1023/B:GLYC.0000014072.34840.04
13. N Bidon-Wagner JP Le Pennec 2004 Human galectin-8 isoforms and cancer Glycoconj J 19 557 63 10.1023/B:GLYC.0000014086.38343.98 14758080 10.1023/B:GLYC.0000014086.38343.98
14. YR Hadari M Eisenstein R Zakut 1997 Galectin-8: on the road from structure to function Trends Glycosci Glycotechnol 9 103 12 1:CAS:528: DyaK2sXisFCms7Y%3D
15. Y Levy, et al. 2001 Galectin-8 functions as matricellular modulator of cell adhesion J Biol Chem 276 31285 95 10.1074/jbc.M100340200 11371555 10.1074/jbc.M100340200 1:CAS:528:DC%2BD3MXmsVejsLs%3D (Pubitemid 37384999)
16. A Danguy, et al. 2001 Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system Histol Histopathol 16 861 8 11510978 1:STN:280:DC%2BD3MvmsFGmuw%3D%3D
17. N Nagy, et al. 2003 Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting Cancer 97 1849 58 10.1002/cncr.11268 12673710 10.1002/cncr.11268 (Pubitemid 36397258)
18. R Bassen, et al. 1999 Expression of Po66-CBP, a type-8 galectin, in different healthy, tumoral and peritumoral tissues Anticancer Res 19 5429 33 10697573 1:CAS:528:DC%2BD3cXhsFaiurw%3D
19. XC Xu AK El-Naggar R Lotan 1995 Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications Am J Pathol 147 815 22 7677193 1:CAS:528:DyaK2MXoslKjtrk%3D
20. PL Fernandez, et al. 1997 Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue J Pathol 181 80 6 10.1002/(SICI)1096- 9896(199701)181:1<80::AID-PATH699>3.0.CO;2-E 9072007 10.1002/(SICI)1096- 9896(199701)181:1<80::AID-PATH699>3.0.CO;2-E 1:STN:280: DyaK2s3isFKltw%3D%3D (Pubitemid 27099778)
21. F Orlandi, et al. 1998 Galectin-3 is a presurgical marker of human thyroid carcinoma Cancer Res 58 3013 20
22. H Inohara, et al. 1999 Expression of galectin-3 in fine needle aspirates as a differential diagnostic marker between benign and malignant thyroid neoplasms Cancer 85 2475 84 10.1002/(SICI)1097-0142(19990601)85:11<2475::AID- CNCR25>3.0.CO;2-1 10357421 10.1002/(SICI)1097-0142(19990601)85:11<2475:: AID-CNCR25>3.0.CO;2-1 1:STN:280:DyaK1M3osVeisQ%3D%3D (Pubitemid 29244859)
23. A Bartolazzi, et al. 2001 Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions Lancet 357 1644 50 10.1016/S0140-6736(00)04817-0 11425367 10.1016/S0140-6736(00)04817-0 1:STN:280:DC%2BD3MzmtlGktw%3D%3D (Pubitemid 32568236)
24. E Saggiorato, et al. 2001 Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma J Clin Endocrinol Metab 86 5152 8 10.1210/jc.86.11.5152 11701669 10.1210/jc.86.11.5152 1:CAS:528:DC%2BD3MXos1Kqsr8%3D (Pubitemid 33070230)
25. D Cvejic, et al. 1998 Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue Anticancer Res 18 2637 42 9703921 1:CAS:528:DyaK1cXlsF2htrk%3D
26. L Martins, et al. 2002 Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors J Clin Endocrinol Metab 87 4806 10 10.1210/jc.2002-020094 12364477 10.1210/jc.2002-020094 1:CAS:528: DC%2BD38XnvFCrtrY%3D (Pubitemid 35247079)
27. ME Herrmann, et al. 2002 Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions Arch Pathol Lab Med 126 710 3 12033961 1:CAS:528:DC%2BD38XltVWitLg%3D
28. RB Kovács J Földes G Winkler M Bodó Z Sápi 2003 The investigation of galectin-3 in diseases of the thyroid gland Eur J Endocrinol 149 449 53 10.1530/eje.0.1490449 14585093 10.1530/eje.0.1490449 (Pubitemid 37461528)
29. J Feilchenfeldt, et al. 2003 Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry Mod Pathol 16 1117 23 10.1097/01.MP.0000096047.99202.31 14614051 10.1097/01.MP.0000096047. 99202.31 (Pubitemid 37414206)
30. P Mehrotra, et al. 2004 Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms Histopathology 45 493 500 10.1111/j.1365-2559. 2004.01978.x 15500653 10.1111/j.1365-2559.2004.01978.x 1:STN:280: DC%2BD2crjtVOksw%3D%3D (Pubitemid 39524324)